Soluble CD33 for treating myelodysplastic syndromes (MDS) Grant US-11584787-B2 United States of America 21 Feb 2023
Soluble CD33 for treating myelodysplastic syndromes (MDS) Grant US-10344072-B2 United States of America 09 Jul 2019
Methods and compositions for enhancing an immune response, blocking monocyte migration… Grant US-10206983-B2 United States of America 19 Feb 2019
VACCINE COMPRISING MONOCYTE OR IMMATURE MYELOID CELLS(IMC) WHICH WERE LOADED WITH THE… Grant EP-2227253-B1 European Patent Office 17 May 2017
Methods and compositions for enhancing an immune response, blocking monocyte migration… Grant US-9539314-B2 United States of America 10 Jan 2017
Myeloid derived suppressor cell inhibiting agents Grant US-9320735-B2 United States of America 26 Apr 2016
Methods and compositions for enhancing an immune response, blocking monocyte migration… Grant US-8975290-B2 United States of America 10 Mar 2015
CROWN-LIKE STRUCTURES AS A BIOMARKER FOR CANCER RISK AND CANCER PROGNOSIS Application WO-2012109632-A3 World Intellectual Property Organisation (WIPO) 03 Apr 2014
CROWN-LIKE STRUCTURES AS A BIOMARKER FOR CANCER RISK AND CANCER PROGNOSIS Application WO-2012109632-A2 World Intellectual Property Organisation (WIPO) 16 Aug 2012
PLATFORM TECHNOLOGIES FOR SPONTANEOUSLY OCCURRING DISEASES Application WO-2010132847-A1 World Intellectual Property Organisation (WIPO) 18 Nov 2010